Jake R. Morgan
About
Jake R. Morgan is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions.
According to data from OpenAlex, Jake R. Morgan has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 40 papers in Public Health, Environmental and Occupational Health and 16 papers in General Health Professions. Recurrent topics in Jake R. Morgan's work include Opioid Use Disorder Treatment (38 papers), Substance Abuse Treatment and Outcomes (23 papers) and Prenatal Substance Exposure Effects (15 papers). Jake R. Morgan is often cited by papers focused on Opioid Use Disorder Treatment (38 papers), Substance Abuse Treatment and Outcomes (23 papers) and Prenatal Substance Exposure Effects (15 papers). Jake R. Morgan collaborates with scholars based in United States, Switzerland and United Kingdom. Jake R. Morgan's co-authors include Benjamin P. Linas, Bruce R. Schackman, Alexander Y. Walley, Jared A. Leff, Joshua A. Barocas, Mari‐Lynn Drainoni, Sean M. Murphy, Jianing Wang, Zoe Weinstein and Sabrina A. Assoumou and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.
In The Last Decade
Jake R. Morgan
68 papers receiving 1.4k citations
Peers
Jake R. Morgan
Joshua A. Barocas United States
Mai T. Pho United States
Jeong Eun Min Canada
Aaron D. Fox United States
Margot Kuo Canada
Alice Asher United States
Jack Stone United Kingdom
Barbara Broers Switzerland
Simeon D. Kimmel United States
Ashly E. Jordan United States
Citations per year, relative to Jake R. Morgan Jake R. Morgan (= 1×)
peers
Joshua A. Barocas
Countries citing papers authored by Jake R. Morgan
Since
Specialization
Citations
This map shows the geographic impact of Jake R. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake R. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake R. Morgan more than expected).
Fields of papers citing papers by Jake R. Morgan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jake R. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake R. Morgan. The network helps show where Jake R. Morgan may publish in the future.
Co-authorship network of co-authors of Jake R. Morgan
This figure shows the co-authorship network connecting the top 25 collaborators of Jake R. Morgan. A scholar is included among the top collaborators of Jake R. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake R. Morgan. Jake R. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Levengood, Timothy W., Xiao Zang, Bruce R. Schackman, et al.. (2025). A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug and Alcohol Dependence. 274. 112783–112783.
2.
Merchant, Roland C., Nancy Grant Harrington, Melissa A. Clark, et al.. (2024). Testing a persuasive health communication intervention (PHCI) for emergency department patients who declined rapid HIV/HCV screening: a randomised controlled trial study protocol. BMJ Open. 14(8). e089265–e089265.
3.
Zang, Xiao, Czarina N. Behrends, Avik Chatterjee, et al.. (2024). Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community‐based naloxone distribution strategies in Massachusetts, United States. Addiction. 120(2). 316–326.
4.
Morgan, Jake R., Sharon Reif, Maureen T. Stewart, Marc R. Larochelle, & Rachel Sayko Adams. (2024). Characterizing the Association Between Traumatic Brain Injury and Discontinuation of Medications for Opioid Use Disorder in a Commercially Insured Adult Population. Journal of Head Trauma Rehabilitation. 40(2). E111–E120.
5.
Aldridge, Arnie, et al.. (2023). Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths. Journal of Addiction Medicine. 18(1). 13–18.
6.
Leech, Ashley A., Elizabeth McNeer, Andrew W. Roberts, et al.. (2023). Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder. JAMA Internal Medicine. 183(9). 1023–1023.
7.
Morgan, Jake R. & Sabrina A. Assoumou. (2023). The limits of innovation: Directly addressing known challenges is necessary to improve the real‐world experience of novel medications for opioid use disorder. Academic Emergency Medicine. 30(12). 1285–1287.
8.
Savinkina, Alexandra, R. W. M. A. Madushani, Golnaz Eftekhari Yazdi, et al.. (2022). Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness analysis. Addiction. 117(9). 2450–2461.
9.
Epstein, Rachel, Jianing Wang, Laura F. White, et al.. (2022). Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured. American Journal of Preventive Medicine. 63(3). e87–e98.
10.
Morgan, Jake R., et al.. (2022). Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder. Journal of Substance Abuse Treatment. 140. 108800–108800.
11.
Morgan, Jake R., Sean M. Murphy, Sabrina A. Assoumou, & Benjamin P. Linas. (2022). Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees. Journal of Occupational and Environmental Medicine. 64(11). 899–904.
12.
Zang, Xiao, Avik Chatterjee, Czarina N. Behrends, et al.. (2021). Community‐based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 117(5). 1372–1381.
13.
Morgan, Jake R., Alexander Y. Walley, Sean M. Murphy, et al.. (2021). Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug and Alcohol Dependence. 225. 108764–108764.
14.
Morgan, Jake R., et al.. (2021). HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients. Advances in Therapy. 38(3). 1690–1700.
15.
Zang, Xiao, Alexandria Macmadu, Maxwell S. Krieger, et al.. (2021). Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. International Journal of Drug Policy. 98. 103435–103435.
16.
Carey, Kathleen & Jake R. Morgan. (2020). Payments for outpatient joint replacement surgery: A comparison of hospital outpatient departments and ambulatory surgery centers. Health Services Research. 55(2). 218–223.
17.
Aldridge, Arnie, Carolina Barbosa, Joshua A. Barocas, et al.. (2020). Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug and Alcohol Dependence. 217. 108336–108336.
18.
Schackman, Bruce R., Sarah Gutkind, Jake R. Morgan, et al.. (2018). Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug and Alcohol Dependence. 185. 411–420.
19.
Morgan, Jake R., Mari‐Lynn Drainoni, Claus Christiansen, & Tamar F. Barlam. (2017). Patient-Provider Race and Sex Concordance: New Insights into Antibiotic Prescribing for Acute Bronchitis. Digital Scholarship - UNLV (University of Nevada Reno). 10(4). 6.
20.
Perkins, Rebecca B., et al.. (2016). Gynecologic Outcomes After Hysteroscopic and Laparoscopic Sterilization Procedures. Obstetrics and Gynecology. 128(4). 843–852.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Joshua A. Barocas Breakdown of academic impact, for papers by Mai T. Pho Breakdown of academic impact, for papers by Jeong Eun Min Breakdown of academic impact, for papers by Aaron D. Fox Breakdown of academic impact, for papers by Margot Kuo Breakdown of academic impact, for papers by Alice Asher Breakdown of academic impact, for papers by Jack Stone Breakdown of academic impact, for papers by Barbara Broers Breakdown of academic impact, for papers by Simeon D. Kimmel Breakdown of academic impact, for papers by Ashly E. Jordan